Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus (Q40526582)

21 September 2017

Oncolysis of multifocal hepatocellular carcinoma in the rat liver by hepatic artery infusion of vesicular stomatitis virus (English)

1 reference

21 September 2017

1 reference

Katsunori Shinozaki

1

1 reference

21 September 2017

Oliver Ebert

2

1 reference

21 September 2017

Chryssanthi Kournioti

3

1 reference

21 September 2017

Yun-Sheng Tai

4

1 reference

21 September 2017

Savio L C Woo

5

1 reference

21 September 2017

1 March 2004

1 reference

21 September 2017

1 reference

21 September 2017

9

1 reference

21 September 2017

3

1 reference

21 September 2017

368-376

1 reference

Evidence-Based Health Policy---Lessons from the Global Burden of Disease Study

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Estimating the world cancer burden: Globocan 2000.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Rising incidence of hepatocellular carcinoma in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Epidemiology of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Factors affecting the prognosis of primary liver carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Liver transplantation for hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

The murine double-stranded RNA-dependent protein kinase PKR is required for resistance to vesicular stomatitis virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Reovirus therapy of tumors with activated Ras pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Systemic therapy of myeloma xenografts by an attenuated measles virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Gene therapy for malignant liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

A novel tumor-specific replication-restricted adenoviral vector for gene therapy of hepatocellular carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Telomerase-dependent oncolytic adenovirus for cancer treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Hepatoma-specific antitumor activity of an albumin enhancer/promoter regulated herpes simplex virus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Effective infection, apoptotic cell killing and gene transfer of human hepatoma cells but not primary hepatocytes by parvovirus H1 and derived vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Vesicular stomatitis virus infects and matures only through the basolateral surface of the polarized epithelial cell line, MDCK.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Control of early viral and bacterial distribution and disease by natural antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Immune responses in interleukin-2-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Neoadjuvant treatment of hepatic malignancy: an oncolytic herpes simplex virus expressing IL-12 effectively treats the parent tumor and protects against recurrence-after resection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Expression of a fusogenic membrane glycoprotein by an oncolytic herpes simplex virus potentiates the viral antitumor effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Genetically engineered vesicular stomatitis virus in gene therapy: application for treatment of malignant disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Development of recombinant vesicular stomatitis viruses that exploit defects in host defense to augment specific oncolytic activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Recombinant vesicular stomatitis viruses from DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.004

10.1016/J.YMTHE.2003.12.004

7 January 2021

Identifiers

DOI

1 reference

release_75zc35d36fhnfos3ryrk44lufe

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/75zc35d36fhnfos3ryrk44lufe

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference